Status: current, Not sufficiently defined by necessary conditions definition status. Date: 22-Sep 2010. Module: SNOMED CT United Kingdom drug extension module
Descriptions:
| Id | Description | Lang | Type | Status | Case? | Module |
| 61915401000001117 | Daxas | en | Synonym | Active | Only initial character case insensitive | SNOMED CT United Kingdom drug extension module |
| 61915501000001118 | Daxas (product) | en | Fully specified name | Active | Only initial character case insensitive | SNOMED CT United Kingdom drug extension module |
| Outbound Relationships | Type | Target | Active | Characteristic | Refinability | Group | Values |
| Daxas | Is a | Trade family | true | Inferred relationship | Existential restriction modifier |
| Inbound Relationships | Type | Active | Source | Characteristic | Refinability | Group |
| Daxas 500microgram tablets (Mawdsley-Brooks & Company Ltd) | Is a | True | Daxas | Inferred relationship | Existential restriction modifier | |
| Daxas 500microgram tablets (Merck Sharp & Dohme Ltd) | Is a | True | Daxas | Inferred relationship | Existential restriction modifier | |
| Daxas 250microgram tablets (AstraZeneca UK Ltd) | Is a | True | Daxas | Inferred relationship | Existential restriction modifier |
This concept is not in any reference sets
FHIR